Hybrid Technologies for Enhanced Clinical Outcomes:
Med-tech companies are driving innovation in the IVUS devices market by integrating intravascular ultrasound with optical coherence tomography (OCT). This hybrid approach enhances the visualization of intracoronary structures, crucial for diagnosing complex conditions like left main coronary artery disease. The choice between imaging modalities is becoming increasingly dependent on specific anatomic and patient characteristics. This trend is steering the market towards a projected value surpassing US$ 1.22 billion by 2031.
Get Free Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2208
Revolutionizing Diagnosis with Micromachined Ultrasound Transducers:
Overcoming limitations associated with traditional piezoelectric ultrasound transducers, companies are investing in micromachined ultrasound transducers. These devices offer high-resolution images, serving as both transmitters and detectors. The focus on microelectromechanical system (MEMS) technology is a key strategy to address challenges in fabricating high-density arrays, ensuring accelerated imaging speeds, and minimizing motion artifacts. This shift in technology is poised to enhance the overall image quality in IVUS.